Ask a patient four quick questions before you induce, and the Apfel score turns their answers into a number — a real, validated prediction of how likely they are to wake up nauseated. It's become the standard first pass for PONV risk in anesthesia practice precisely because it's this fast.
Four factors, and nothing else
The original research behind the score tested a long list of candidate risk factors — patient history, anesthetic technique, surgical variables — and found that once you control for the strongest predictors, most of the rest add almost nothing. Four factors survived: each is independently predictive, and every one can be answered in a preop interview without a chart review.
- Female sex
- A history of PONV or motion sickness
- Nonsmoker status (smoking is protective — nonsmokers score the point)
- Planned postoperative opioids
Each factor is worth exactly one point. No weighting, no interaction terms, no lookup table. That simplicity is the entire point — you can compute the score in the time it takes to ask the four questions.
The number turns into a probability
The score isn't just a tally. In the validation cohort, it mapped directly onto how often patients in each bucket actually vomited after surgery with no prophylaxis on board:
- 0 factors — about 10% incidence
- 1 factor — about 21% incidence
- 2 factors — about 39% incidence
- 3 factors — about 61% incidence
- 4 factors — about 79% incidence
That's roughly an eightfold spread between a 0/4 patient and a 4/4 patient — which is exactly why the score exists: to tell you how hard to fight before you've picked up a single syringe.
What you actually do with the score
The Gan Consensus Guidelines translate the number into a prophylaxis plan. Low risk (0-1) doesn't need routine multi-agent coverage — a single low-cost agent is reasonable, and on a short case, skipping prophylaxis entirely is defensible. Moderate risk (2) is where prophylaxis earns its keep: two antiemetics from different classes, typically a 5-HT3 antagonist like ondansetron plus dexamethasone. High risk (3-4) calls for going multimodal — three or four agents from different classes, often adding an NK1 antagonist, droperidol, or scopolamine on top of that pair.
None of that replaces judgment. A 0/4 patient having a long, high-emetogenic case can still merit prophylaxis; a 4/4 patient under local for twenty minutes can reasonably go without. The score tells you where to start, not where to stop thinking.
Where Master Anesthesia comes in
Working this out in your head between cases is exactly the kind of math that's easy to get wrong under time pressure. the PONV Risk Calculator does it for you — tap the four factors and get the score, the incidence, and the exact prophylaxis tier in one glance.